Home Cart 0 Sign in  
X

[ CAS No. 51012-65-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 51012-65-8
Chemical Structure| 51012-65-8
Chemical Structure| 51012-65-8
Structure of 51012-65-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 51012-65-8 ]

Related Doc. of [ 51012-65-8 ]

Alternatived Products of [ 51012-65-8 ]

Product Details of [ 51012-65-8 ]

CAS No. :51012-65-8 MDL No. :MFCD04038955
Formula : C9H9BrO Boiling Point : -
Linear Structure Formula :- InChI Key :XMGAXELQRATLJP-UHFFFAOYSA-N
M.W : 213.07 Pubchem ID :12430676
Synonyms :

Calculated chemistry of [ 51012-65-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 49.47
TPSA : 17.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.95
Log Po/w (XLOGP3) : 3.51
Log Po/w (WLOGP) : 2.57
Log Po/w (MLOGP) : 2.55
Log Po/w (SILICOS-IT) : 3.17
Consensus Log Po/w : 2.75

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.64
Solubility : 0.0484 mg/ml ; 0.000227 mol/l
Class : Soluble
Log S (Ali) : -3.55
Solubility : 0.0598 mg/ml ; 0.000281 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.0
Solubility : 0.0215 mg/ml ; 0.000101 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.62

Safety of [ 51012-65-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501 UN#:3261
Hazard Statements:H302-H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 51012-65-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 51012-65-8 ]
  • Downstream synthetic route of [ 51012-65-8 ]

[ 51012-65-8 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 51012-65-8 ]
  • [ 17356-08-0 ]
  • [ 5330-79-0 ]
Reference: [1] MedChemComm, 2015, vol. 6, # 6, p. 1036 - 1042
  • 2
  • [ 933-88-0 ]
  • [ 18107-18-1 ]
  • [ 51012-65-8 ]
YieldReaction ConditionsOperation in experiment
91% With hydrogen bromide In hexane; water; ethyl acetate; acetonitrile Example 6
Preparation of 2-bromo-1-o-tolylethanone (I15)
To a solution of 2-methylbenzoyl chloride (169 μl, 1.29 mmol) in dry acetonitrile (5 ml) and cooled at 0° C., under nitrogen atmosphere, was added (diazomethyl)-trimethylsilane (1.94 ml, 3.88 mmol, 2M in hexane).
The reaction was stirred at room temperature for 15 hours, then it was cooled at 0° C. and 48percent HBr (512 μl, 4.53 mmol) was slowly added.
The reaction was stirred at room temperature for 3 hours.
EtOAc and water were added, the organic layer was separated and the aqueous phase was neutralized with 1M NaOH and extracted with EtOAc.
The combined organic layers were dried over Na2SO4, filtered and evaporated to dryness to obtain 2-bromo-1-o-tolylethanone (250 mg, 91percent yield).
This intermediate was used in the next step without any further purification.
1H NMR (300 MHz, DMSO-d6) δ ppm 7.82-7.91 (m, 1H), 7.45-7.52 (m, 1H), 7.25-7.40 (m, 2H), 4.86 (s, 2H), 2.41 (s, 3H).
91%
Stage #1: at 0 - 20℃; for 15 h; Inert atmosphere
Stage #2: With hydrogen bromide In hexane; water; acetonitrile at 0 - 20℃; for 3 h;
To a solution of 2-methylbenzoyl chloride (169 μ, 1.29 mmol) in dry acetonitrile (5 ml) and cooled at 0°C, under nitrogen atmosphere, (diazomethyl)trimethylsilane (1.94 ml, 3.88 mmol, 2M in hexane) was added. The reaction was stirred at room temperature for 15h, then it was cooled at 0°C and 48percent HBr (512 μ, 4.53 mmol) was slowly added. The reaction was stirred at room temperature for 3h. EtOAc and water were added, the organic layer was separated and the aqueous phase was neutralized with 1M NaOH and extracted with EtOAc. The combined organic layers were dried over Na2SO4, filtered and evaporated to dryness to obtain 2-bromo-l-o- tolylethanone (250 mg, 91percent yield). This intermediate was used in the next step without any further purification.1H NMR (300 MHz, DMSO- 6) δ ppm 7.82 - 7.91 (m, 1 H), 7.45 - 7.52 (m, 1 H), 7.25 - 7.40 (m, 2 H), 4.86 (s, 2 H), 2.41 (s, 3 H).
Reference: [1] Patent: US2011/311458, 2011, A1,
[2] Patent: WO2011/161018, 2011, A1, . Location in patent: Page/Page column 35
  • 3
  • [ 577-16-2 ]
  • [ 65523-96-8 ]
  • [ 51012-65-8 ]
YieldReaction ConditionsOperation in experiment
90% With N-Bromosuccinimide; silica gel In methanol for 0.283333 h; Reflux General procedure: The α-bromination reaction was carried out using acetophenone (1200 mg, 10 mmol), N-bromosuccinimide (2136 mg, 12 mmol), 10percent (w/w) silica gel (120mg) in 10 mL of methanol at reflux conditions until the disappearance of the substrate. (Note: 2136mg of N-bromosuccinimide was added portion wise i.e. 356 mg for each time in six portions). The progress of the reaction was monitored by TLC. The reaction mass was filtered after the completion of the reaction as per TLC and the catalyst was collected for reuse. The filtrate was concentrated under vacuum. Double distilled water was added to the reaction mixture and quenched with aqueous sodium thiosulfate and the product extracted with dichloromethane (Caution: Severe burning sensation of eyes was observed during the work-up process). The layers were separated and the organic layer was collected and washed thrice with distilled water (3×50mL). The collected organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The obtained crude product was purified by column chromatography over silica gel (60–120 mesh) using n-hexane–EtOAc (99:1 ratio). With the aim of studying the recycling of the catalyst, the isolated catalyst was washed with ethyl acetate (5mL) after its filtration from the reaction medium, collected and dried in vacuum at 70°C to a constant weight. Subsequently it was reused for the α-bromination of acetophenone and achieved 95percent, 86percent and 83percent yields of product (2a) for first, second and third reuse of catalyst respectively. All products gave spectroscopic data in agreement with the literature [15,21,27–30]. The method is also very practical for scale up in process development. We attempted large scale (100 gram scale) synthesis of 2-bromo-1-phenylethanone 2a and obtained fruitful results with isolated yields ranging from 93percent to 96percent.
47% With trimethylsilyl bromide; potassium nitrate In dichloromethane at 20℃; for 16 h; General procedure: In a Nalgene.(R). bottle, to acetophenone (2 mmol) in dichloromethane (10 mL), potassium nitrate (4 mmol) and chloro/bromotrimethylsilane (8 mmol) were added. The heterogeneous mixture was stirred vigorously at 60 °C (for chlorination) or room temperature (for bromination) until the reaction went to completion (monitored by 1H NMR spectroscopy). The reaction mixture was then filtered and solvent removed under reduced pressure. The chlorinated/brominated acetophenone derivatives were obtained upon purification by flash chromatography (silica gel) with hexane as eluent. The products were characterized by comparing their spectroscopic data with those of the authentic samples.
Reference: [1] Chinese Chemical Letters, 2014, vol. 25, # 1, p. 179 - 182
[2] Tetrahedron Letters, 2011, vol. 52, # 11, p. 1217 - 1221
  • 4
  • [ 577-16-2 ]
  • [ 51012-65-8 ]
YieldReaction ConditionsOperation in experiment
92% With Oxone; ammonium bromide In methanol at 20℃; for 26 h; General procedure: Oxone (1.352 g, 2.2 mmol) was added to the well stirred solution of substrate (2 mmol) and NH4Br (0.215 g, 2.2 mmol) in methanol (10 ml) and the reaction mixture was allowed to stir at room temperature (or reflux temperature). After completion of the reaction, as monitored by TLC, the reaction mixture was quenched with aqueous sodium thiosulfate, and extracted with ethyl acetate (3.x.25 ml). Finally, the combined organic layer was washed with water, dried over anhydrous sodium sulfate, filtered and removal of solvent in vacuo yielded a crude residue, which was further purified by column chromatography over silica gel (finer than 200 mesh) to afford pure products. All the products were identified on the basis of 1H NMR and mass spectral data.
52.5% With pyridinium hydrobromide perbromide; hydrogen bromide; acetic acid In water at 0 - 20℃; for 3 h; Intermediate 9: 2-Bromo-1-(2-methylphenyl) ethanoneTo a 250 mL RB flask fitted with magnetic stirrer was charged 60 mL of Acetic acid. To the stirred solvent was added 1-o-tolyl-ethanone (3.0 g, 22.35 mmol) RM cooled to 0 was added 47percent hydrobromic acid (9.7 mL, 178.63 mmol), pyridinium hydro bromide per bromide (8.6 g, 26.89 mmol) slowly. The resulting mixture was stirred at RT for 3 h. The RM was then quenched with 10percent sodium bicarbonate solution in water (150 mL) at 0 and extracted with ethyl acetate (75 mL X 2). The organic layer was washed with saturated brine solution (50 mL) and dried over anhydrous Na2S04 and evaporated to dryness. The crude compound thus obtained was purified by column chromatography on silica gel (100/200 mesh), using petroleum ether (60-80) and ethyl acetate (ratio) as eluent to give the product (2.50 g, yield: 52.5percent)
96% With hydrogenchloride; bromine In diethyl ether; acetic acid a.
2'-Methylacetophenone (25.0 g, 186 mMole) was dissolved in glacial acetic acid (250 ml) and concentrated HCl (250 uL) was added followed by a dropwise addition of bromine (9.6 ml, 186 mmole) over 15 minutes.
The mixture was stirred 3 hours and then concentrated under reduced pressure.
The residue was taken up in ethyl ether and washed with saturated NaHCO3 solution.
The ether layer was dried over Na2SO4, filtered, and concentrated to yield 38.0 g, (96percent) of crude 2-bromo-2'-methylacetophenone which was used without further purification.
167 g With pyridinium hydrobromide perbromide In ethyl acetate for 1 h; 2'-methylacetophenone (100 g), stirred mixture of ethyl acetate (800 mL)While, was added Pyridinium bromide perbromide(252g). The reaction solution After stirring for 1 hour.The addition of water (500 mL), to remove the separated water layer. The obtained organic layer, 1 N hydrochloric acid (500 mL), then washed with saturated color fountain (500 mL), washed with 5percent aqueous sodium thiosulfate solution (500 mL). The resulting organic layer was dried over sodium sulfate, and concentrated to give, to give the intermediate 301F (167g).

Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 2, p. 191 - 195
[2] Synthetic Communications, 2013, vol. 43, # 19, p. 2603 - 2614
[3] Archiv der Pharmazie, 1993, vol. 326, # 5, p. 253 - 258
[4] Organic Letters, 2016, vol. 18, # 4, p. 852 - 855
[5] Patent: WO2012/11125, 2012, A1, . Location in patent: Page/Page column 67-68
[6] Journal of the Chemical Society, 1938, p. 445,447
[7] Journal of the Chemical Society, 1935, p. 997,999
[8] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 3, p. 601 - 621
[9] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 5, p. 1291 - 1295
[10] Patent: US2002/13319, 2002, A1,
[11] Patent: US6020342, 2000, A,
[12] Patent: US4626543, 1986, A,
[13] Patent: EP1803709, 2007, A1,
[14] Patent: WO2006/36024, 2006, A1, . Location in patent: Page/Page column 107-108; 284
[15] Patent: WO2006/36024, 2006, A1, . Location in patent: Page/Page column 138-139; 287
[16] Patent: US2011/306769, 2011, A1, . Location in patent: Page/Page column 27
[17] Patent: WO2012/27965, 2012, A1, . Location in patent: Page/Page column 17
[18] Journal of Medicinal Chemistry, 2013, vol. 56, # 1, p. 84 - 96
[19] Tetrahedron Letters, 2013, vol. 54, # 52, p. 7175 - 7179
[20] Chemistry - A European Journal, 2014, vol. 20, # 20, p. 5983 - 5993
[21] European Journal of Organic Chemistry, 2014, vol. 2014, # 34, p. 7707 - 7715
[22] MedChemComm, 2015, vol. 6, # 6, p. 1036 - 1042
[23] Chemical Biology and Drug Design, 2015, vol. 86, # 4, p. 849 - 856
[24] Patent: EP2336107, 2015, B1, . Location in patent: Paragraph 0197
[25] Phosphorus, Sulfur and Silicon and the Related Elements, 2016, vol. 191, # 8, p. 1166 - 1173
[26] Patent: JP5827901, 2015, B2, . Location in patent: Paragraph 0214; 0215
[27] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 13, p. 3298 - 3314
[28] Organic Letters, 2017, vol. 19, # 11, p. 2877 - 2880
[29] Organic and Biomolecular Chemistry, 2017, vol. 15, # 38, p. 8134 - 8139
[30] Patent: US2018/44284, 2018, A1, . Location in patent: Paragraph 0172; 0173
[31] Advanced Synthesis and Catalysis, 2018, vol. 360, # 8, p. 1628 - 1633
[32] Tetrahedron Letters, 2018, vol. 59, # 33, p. 3214 - 3219
  • 5
  • [ 577-16-2 ]
  • [ 51012-65-8 ]
Reference: [1] Patent: US5859035, 1999, A,
  • 6
  • [ 611-15-4 ]
  • [ 51012-65-8 ]
Reference: [1] Organic and Biomolecular Chemistry, 2016, vol. 14, # 48, p. 11389 - 11395
[2] Synlett, 2010, # 15, p. 2335 - 2339
  • 7
  • [ 577-16-2 ]
  • [ 51012-65-8 ]
Reference: [1] Patent: EP885869, 1998, A1,
  • 8
  • [ 933-88-0 ]
  • [ 51012-65-8 ]
Reference: [1] Journal of the Chemical Society, 1935, p. 997,999
[2] Journal of the Chemical Society, 1938, p. 445,447
  • 9
  • [ 75-15-0 ]
  • [ 7446-70-0 ]
  • [ 106-38-7 ]
  • [ 75-36-5 ]
  • [ 51012-65-8 ]
Reference: [1] Chemische Berichte, 1922, vol. 55, p. 2056
[2] Justus Liebigs Annalen der Chemie, 1941, vol. 546, p. 277,291
  • 10
  • [ 75-15-0 ]
  • [ 7446-70-0 ]
  • [ 95-46-5 ]
  • [ 75-36-5 ]
  • [ 51012-65-8 ]
Reference: [1] Chemische Berichte, 1922, vol. 55, p. 2056
[2] Justus Liebigs Annalen der Chemie, 1941, vol. 546, p. 277,291
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 51012-65-8 ]

Aryls

Chemical Structure| 51012-64-7

[ 51012-64-7 ]

2-Bromo-1-(m-tolyl)ethan-1-one

Similarity: 0.95

Chemical Structure| 2632-14-6

[ 2632-14-6 ]

2-Bromo-1-(4-ethylphenyl)ethanone

Similarity: 0.95

Chemical Structure| 619-41-0

[ 619-41-0 ]

2-Bromo-1-(p-tolyl)ethanone

Similarity: 0.95

Chemical Structure| 13672-07-6

[ 13672-07-6 ]

2-Bromo-3,4-dihydronaphthalen-1(2H)-one

Similarity: 0.93

Chemical Structure| 22901-09-3

[ 22901-09-3 ]

2-(2-Bromoethyl)benzaldehyde

Similarity: 0.86

Bromides

Chemical Structure| 51012-64-7

[ 51012-64-7 ]

2-Bromo-1-(m-tolyl)ethan-1-one

Similarity: 0.95

Chemical Structure| 2632-14-6

[ 2632-14-6 ]

2-Bromo-1-(4-ethylphenyl)ethanone

Similarity: 0.95

Chemical Structure| 619-41-0

[ 619-41-0 ]

2-Bromo-1-(p-tolyl)ethanone

Similarity: 0.95

Chemical Structure| 13672-07-6

[ 13672-07-6 ]

2-Bromo-3,4-dihydronaphthalen-1(2H)-one

Similarity: 0.93

Chemical Structure| 22901-09-3

[ 22901-09-3 ]

2-(2-Bromoethyl)benzaldehyde

Similarity: 0.86

Ketones

Chemical Structure| 51012-64-7

[ 51012-64-7 ]

2-Bromo-1-(m-tolyl)ethan-1-one

Similarity: 0.95

Chemical Structure| 2632-14-6

[ 2632-14-6 ]

2-Bromo-1-(4-ethylphenyl)ethanone

Similarity: 0.95

Chemical Structure| 619-41-0

[ 619-41-0 ]

2-Bromo-1-(p-tolyl)ethanone

Similarity: 0.95

Chemical Structure| 13672-07-6

[ 13672-07-6 ]

2-Bromo-3,4-dihydronaphthalen-1(2H)-one

Similarity: 0.93

Chemical Structure| 30095-47-7

[ 30095-47-7 ]

2-Bromo-1-(4-(tert-butyl)phenyl)ethanone

Similarity: 0.85